Skip to content
Back to ORMP

Oramed Pharmaceuticals Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
4
Purchases
0
Sales
4
Purchase value
$0.00
Sale value
$1.17M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Avraham GabayChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Oct 2, 2026Period of report Oct 1, 20260001213900-26-106531
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 1, 2026
Common StockF1F220,000$4.51$90.20K861,076Direct
Filing footnotes · 2
  1. F1Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.440 to $4.650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open on SEC EDGAR
Joshua HexterCOO & CBO
4Rule 10b5-1 plan disclosed
Filed Oct 2, 2026Period of report Oct 1, 20260001213900-26-106530
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 1, 2026
Common StockF1F230,000$4.511$135.33K1,328,130Direct
Filing footnotes · 2
  1. F1Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.440 to $4.650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open on SEC EDGAR
Joshua HexterCOO & CBO
4
Filed Jul 2, 2026Period of report Jul 1, 20260001213900-26-075070
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F2137,000$4.463$611.43K1,023,384Direct
Filing footnotes · 3
  1. F1Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.255 to $4.7652, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. F3The stock options vested and became exercisable in 16 equal installments of 6,250 on the first day of every three-month period beginning November 1, 2019.
Open on SEC EDGAR
Avraham GabayChief Financial Officer
4
Filed Jul 2, 2026Period of report Jul 1, 20260001213900-26-075069
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F273,360$4.5085$330.74K671,785Direct
Filing footnotes · 2
  1. F1Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.255 to $4.750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.